Quoin Pharmaceuticals Ltd

Research Quoin Pharmaceuticals Ltd (QNRX) on Bullrun: market cap USD 9.14M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerQNRX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 9.14M
• Financial periodFY2025
• Net income-USD 15.80M

Valuation Snapshot

latest market cap is USD 9.14M.

About Quoin Pharmaceuticals Ltd

Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage;

Frequently asked questions

What is Quoin Pharmaceuticals Ltd's market cap?

Quoin Pharmaceuticals Ltd's market capitalization is USD 9.14M.

What does Quoin Pharmaceuticals Ltd do?

Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.